USPTO serial 90723353
BENEVOLENT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 11, 2023
- Examiner
- MCCARTHY, JOSEPH PATRICK
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with BENEVOLENT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Leigh Ann Lindquist
Leigh Ann Lindquist SUGHRUE MION, PLLC2000 Pennsylvania Avenue NW, Suite 9000Washington, DC 20006UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable software for data mining, data query, data storage, and database analysis; downloadable software for data processing for use in the fields of healthcare, medicine, pharmaceutical research and scientific research; Downloadable application software for data mining, data query, data storage, and database analysis; Downloadable application software for data processing for use in the fields of healthcare, medicine, pharmaceutical research and scientific research; downloadable computer software for data mining, data query, data storage, and database analysis; downloadable computer software for data processing for use in the fields of healthcare, medicine, pharmaceutical research and scientific research; downloadable computer software platforms for data mining, data query, data storage, and database analysis; downloadable computer software platforms for data processing for use in the fields of healthcare, medicine, pharmaceutical research and scientific research; downloadable computer software for accessing, browsing and searching online databases; downloadable computer software for creating searchable databases of information and data; downloadable computer software to enable searching of data; downloadable computer software for data analysis, pattern discovery, contextual prediction, predictive analytics and predictive modelling; computer hardware and downloadable computer software in relating to artificial intelligence apparatus; artificial intelligence apparatus, namely, home automation hubs using artificial intelligence comprised of voice-activated speakers, computer hardware, and downloadable software for data mining, data query, data storage, and database analysis; artificial intelligence apparatus, namely, home automation hubs using artificial intelligence comprised of voice-activated speakers, computer hardware, and downloadable software for data processing for use in the fields of healthcare, medicine, pharmaceutical research and scientific research; downloadable artificial intelligence software for data mining, data query, data storage, and database analysis; downloadable artificial intelligence software for data processing for use in the fields of healthcare, medicine, pharmaceutical research and scientific research; downloadable artificial intelligence software platforms for data mining, data query, data storage, and database analysis; downloadable artificial intelligence software platforms for data processing for use in the fields of healthcare, medicine, pharmaceutical research and scientific research; downloadable artificial intelligence software for searching, tracking, exploration and analysis of data for use in the field of healthcare, pharmaceuticals and medicines; downloadable artificial intelligence software for searching, tracking, exploration and analysis of data for use in the research and development of pharmaceutical preparations and medicines; downloadable artificial intelligence software for data analysis, pattern discovery, contextual prediction, predictive analytics and predictive modelling; downloadable computer software for the provision of access to computer databases; downloadable computer software for the provision of access to computer computer databases; downloadable computer software for the provision of access to computer data banks; downloadable computer software for the provision of access to computer electronic databases; downloadable computer software for the provision of access to computer interactive databases; downloadable data processing software; downloadable software for data processing programs; downloadable software for data processing systems; downloadable computer programmes for data processing; data recorded electronically from the internet in the field of healthcare, pharmaceuticals and medicines; downloadable data and file management and database software; downloadable data management software; downloadable computer software for the provision of access to computer data engines | ACTIVE | — |
| 035 | Database management; computer database management; collection and compilation of data; data processing services; online data processing services; online data processing services for the pharmaceutical, medical and healthcare industries; providing business information for use in predictive analytics and predictive modelling via computer databases; providing business statistical information for use in predictive analytics and predictive modelling via computer databases; information, advisory and consultancy services relating to all of the aforesaid services; compilation of scientific information | ACTIVE | — |
| 042 | Scientific and technological services, namely, scientific research and analysis in the field of healthcare, pharmaceuticals and medicines; IT integration services; software development, programming and implementation services; design and development of computer software; providing temporary use of online non-downloadable computer software for searching, tracking, exploration and analysis of data for use in the field of healthcare, pharmaceuticals and medicines; providing temporary use of online non-downloadable computer software for searching, tracking, exploration and analysis of data for use in the research and development of pharmaceutical preparations and medicines; Platform as a Service, namely, providing artificial intelligence software platforms; Platform as a Service, namely, providing artificial intelligence software platforms for searching, tracking, exploration and analysis of data for use in the field of healthcare, pharmaceuticals and medicines; Platform as a Service, namely, providing artificial intelligence software platforms for searching, tracking, exploration and analysis of data for use in the research and development of pharmaceutical preparations and medicines; Software as a Service, namely, providing artificial intelligence software; Software as a Service, namely, providing artificial intelligence software for searching, tracking, exploration and analysis of data for use in the field of healthcare, pharmaceuticals and medicines; Software as a Service, namely, providing artificial intelligence software for searching, tracking, exploration and analysis of data for use in the research and development of pharmaceutical preparations and medicines; web site hosting services; hosting platforms on the Internet; providing a web hosting platform of digital content online for data mining, data query, data storage, and database analysis; providing a web hosting platform of digital content online for data processing for use in the fields of healthcare, medicine, pharmaceutical research and scientific research; rental of data mining, data query, data storage, and database analysis software; rental of data processing software for use in the fields of healthcare, medicine, pharmaceutical research and scientific research; computer programming; writing of computer programs for medical applications; writing of computer programs for biotechnological applications; writing of data processing programs; designing data processing systems; database design and development; scientific, pharmacological and medical research, analysis and development services, namely, scientific research and analysis in the field of healthcare, pharmaceuticals and medicines; natural science services, namely, scientific research and analysis in the field of healthcare, pharmaceuticals and medicines; clinical research, namely, scientific research and analysis in the field of healthcare, pharmaceuticals and medicines; scientific research conducted using databases and the Internet, namely, scientific research and analysis in the field of healthcare, pharmaceuticals and medicines; medical research services; pharmaceutical research and development services; pharmaceutical product evaluation; research and development of pharmaceutical preparations, vaccines and medicines; pharmaceutical product research and development; design, development, evaluation and testing of new pharmaceutical products; analysis and evaluation of pharmaceutical product development and design; research and development of pharmaceuticals for the treatment of age-related diseases and cancer; drug discovery services; pharmaceutical drug development services; services for assessing the efficiency of veterinary drugs; services for assessing the efficiency of pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; laboratory services in the field of healthcare, pharmaceuticals and medicines; laboratory analysis, research and testing, namely, scientific research and analysis in the field of healthcare, pharmaceuticals and medicines; consulting services in the fields of pharmaceutical research and development; information technology consulting services for the pharmaceutical and healthcare industries; preparation of scientific and technological reports; providing information about the results of clinical trials for pharmaceutical products for medical and scientific purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; issuing of scientific information in the field of healthcare, pharmaceuticals and medicines; provision of information and data relating to medical, pharmaceutical and healthcare research and development; providing information, advisory and consultancy services regarding information technology services for the pharmaceutical and healthcare industries, all of the aforesaid services also provided online via a database or the Internet; providing information, advisory and consultancy services regarding research and development of pharmaceutical preparations and medicines, all of the aforesaid services also provided online via a database or the Internet; providing information and data relating to veterinary research and development, all of the aforesaid services also provided online via a database or the Internet; information, advisory and consultancy services relating to all of the aforesaid services; compilation of statistical information and data relating to medical research; compilation of statistical information and data relating to scientific research; compilation of information and data for use in the research and development of pharmaceutical preparations and medicines | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BenevolentAI Limited
- Other trademarks owned by BenevolentAI Limited
- Other trademarks owned by BenevolentAI Limited
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named BENEVOLENT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 11, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jul 11, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 5, 2023 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Apr 24, 2023 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Mar 27, 2023 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Mar 27, 2023 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| Mar 14, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 17, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 17, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 28, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 12, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 12, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 12, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 12, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 12, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 12, 2022 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Nov 15, 2022 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Oct 31, 2022 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Oct 28, 2022 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Oct 26, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 26, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 26, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 26, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 26, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 29, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 28, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 28, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 15, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 15, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 15, 2022 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jul 15, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 15, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 15, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 16, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 16, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 16, 2022 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 1, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 1, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 1, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 1, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 17, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 26, 2021 | NWAP | NEW APPLICATION ENTERED | — |